Global Hirudin Market Research 2011- 2022
- HEY1307894
- 70 Pages
- June 2017
- Pharmaceuticals
Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin.
The Global Hirudin market is estimated to reach xxx Million USD in 2017. In the report, HeyReport says Thrombosis Disease dominates the largest Application share in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
By Type
Natural Hirudin
Recombinant Hirudin
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Based on Application, the report describes major Application share of regional market. Application mentioned as follows:
Thrombosis Disease
Tumor Disease
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
The Medicines Company
Teva Pharmaceutical Industries
Pfizer
Pentapharm
DUOPUTAI
Abbott
Keyken
Minapharm
SALUBRIS
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Natural Hirudin
1.2.1.2 Recombinant Hirudin
1.2.2 by Application
1.2.2.1 Thrombosis Disease
1.2.2.2 Tumor Disease
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Global Natural Hirudin Market, 2011-2016
4.1.2 Global Recombinant Hirudin Market, 2011-2016
4.2 Market Forecast
4.2.1 Global Natural Hirudin Market Forecast, 2017-2022
4.2.2 Global Recombinant Hirudin Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Release Agent in Thrombosis Disease Market, 2011-2016
5.1.2 Release Agent in Tumor Disease Market, 2011-2016
5.2 Market Forecast
5.2.1 Hirudin in Thrombosis Disease Market Forecast, 2017-2022
5.2.2 Hirudin in Tumor Disease Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Hirudin Market, 2011-2016
6.1.1.2 Asia-Pacific Hirudin Market by Type
6.1.1.3 Asia-Pacific Hirudin Market by Application
6.1.2 North America
6.1.2.1 North America Hirudin Market, 2011-2016
6.1.2.2 North America Hirudin Market by Type
6.1.2.3 North America Hirudin Market by Application
6.1.3 Europe
6.1.3.1 Europe Hirudin Market, 2011-2016
6.1.3.2 Europe Hirudin Market by Type
6.1.3.3 Europe Hirudin Market by Application
6.1.4 South America
6.1.8.1 South America Hirudin Market, 2011-2016
6.1.8.2 South America Hirudin Market by Type
6.1.8.3 South America Hirudin Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Hirudin Market, 2011-2016
6.1.5.2 Middle East & Africa Hirudin Market by Type
6.1.5.3 Middle East & Africa Hirudin Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Hirudin Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 The Medicines Company
8.1.1 Profile
8.1.2 Business Performance
8.2 Teva Pharmaceutical Industries
8.2.1 Profile
8.2.2 Business Performance
8.3 Pfizer
8.3.1 Profile
8.3.2 Business Performance
8.4 Pentapharm
8.8.1 Profile
8.8.2 Business Performance
8.5 DUOPUTAI
8.5.1 Profile
8.5.2 Business Performance
8.6 Abbott
8.6.1 Profile
8.6.2 Business Performance
8.7 Keyken
8.7.1 Profile
8.7.2 Business Performance
8.8 Minapharm
8.8.1 Profile
8.8.2 Business Performance
8.9 SALUBRIS
8.9.1 Profile
8.9.2 Business Performance
9 Conclusion
List Of Tables
Table Product Specifications of Hirudin
Table Products Segment of Hirudin
Table Natural Hirudin Overview
Table Recombinant Hirudin Overview
Table Global Hirudin Market by Type, 2011-2022 (USD Million)
Table Application Segment of Hirudin
Table Thrombosis Disease Overview
Table Tumor Disease Overview
Table Global Hirudin Market by Application, 2011-2022 (USD Million)
Table Global Hirudin Market by Region, 2011-2022 (USD Million)
Table Cost of Hirudin
Table Market Dynamics
Table Policy of Hirudin
Table Hirudin Market of Global by Vendors, 2011-2016 (USD Million)
Table Hirudin Market of Global by Vendors, 2011-2016 (MT)
Table Price Factors List
Table The Medicines Company Profile List
Table Hirudin Operating Data of The Medicines Company
Table Teva Pharmaceutical Industries Profile List
Table Hirudin Operating Data of Teva Pharmaceutical Industries
Table Pfizer Profile List
Table Hirudin Operating Data of Pfizer
Table Pentapharm Profile List
Table Hirudin Operating Data of Pentapharm
Table DUOPUTAI Profile List
Table Hirudin Operating Data of DUOPUTAI
Table Abbott Profile List
Table Hirudin Operating Data of Abbott
Table Keyken Profile List
Table Hirudin Operating Data of Keyken
Table Minapharm Profile List
Table Hirudin Operating Data of Minapharm
Table SALUBRIS Profile List
Table Hirudin Operating Data of SALUBRIS
List Of Figures
Figure Hirudin Picture
Figure Industry Chain Structure of Hirudin
Figure SWOT of Hirudin
Figure GDP of Major Countries
Figure Natural Hirudin Market Size and Growth, 2011-2016 (USD Million)
Figure Natural Hirudin Market Size and Growth, 2011-2016 (MT)
Figure Recombinant Hirudin Market Size and Growth, 2011-2016 (USD Million)
Figure Recombinant Hirudin Market Size and Growth, 2011-2016 (MT)
Figure Natural Hirudin Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Natural Hirudin Market Estimates and Forecasts, 2017-2022 (MT)
Figure Recombinant Hirudin Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Recombinant Hirudin Market Estimates and Forecasts, 2017-2022 (MT)
Figure Thrombosis Disease Market Size and Growth, 2011-2016 (USD Million)
Figure Thrombosis Disease Market Size and Growth, 2011-2016 (MT)
Figure Tumor Disease Market Size and Growth, 2011-2016 (USD Million)
Figure Tumor Disease Market Size and Growth, 2011-2016 (MT)
Figure Thrombosis Disease Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Thrombosis Disease Market Estimates and Forecasts, 2017-2022 (MT)
Figure Tumor Disease Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Tumor Disease Market Estimates and Forecasts, 2017-2022 (MT)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (MT)
Figure Asia-Pacific Market Size by Type, 2016 (USD Million)
Figure Asia-Pacific Market Share by Type, 2016 (USD Million)
Figure Asia-Pacific Market Size by Application, 2016 (USD Million)
Figure Asia-Pacific Market Share by Application, 2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (MT)
Figure North America Market Size by Type, 2016 (USD Million)
Figure North America Market Share by Type, 2016 (USD Million)
Figure North America Market Size by Application, 2016 (USD Million)
Figure North America Market Share by Application, 2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (MT)
Figure Europe Market Size by Type, 2016 (USD Million)
Figure Europe Market Share by Type, 2016 (USD Million)
Figure Europe Market Size by Application, 2016 (USD Million)
Figure Europe Market Share by Application, 2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (MT)
Figure South America Market Size by Type, 2016 (USD Million)
Figure South America Market Share by Type, 2016 (USD Million)
Figure South America Market Size by Application, 2016 (USD Million)
Figure South America Market Share by Application, 2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (MT)
Figure Middle East & Africa Market Size by Type, 2016 (USD Million)
Figure Middle East & Africa Market Share by Type, 2016 (USD Million)
Figure Middle East & Africa Market Size by Application, 2016 (USD Million)
Figure Middle East & Africa Market Share by Application, 2016 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (MT)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (MT)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (MT)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (MT)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (MT)
Figure Hirudin Market Share of Global by Vendors, 2016 (USD Million)
Figure Hirudin Market Share of Global by Vendors, 2016 (MT)
Figure Hirudin Market Concentration
Figure Marketing Channels Overview
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
